Papers
Topics
Authors
Recent
Gemini 2.5 Flash
Gemini 2.5 Flash
119 tokens/sec
GPT-4o
56 tokens/sec
Gemini 2.5 Pro Pro
43 tokens/sec
o3 Pro
6 tokens/sec
GPT-4.1 Pro
47 tokens/sec
DeepSeek R1 via Azure Pro
28 tokens/sec
2000 character limit reached

Trial2Vec: Zero-Shot Clinical Trial Document Similarity Search using Self-Supervision (2206.14719v2)

Published 29 Jun 2022 in cs.CL, cs.AI, and cs.LG

Abstract: Clinical trials are essential for drug development but are extremely expensive and time-consuming to conduct. It is beneficial to study similar historical trials when designing a clinical trial. However, lengthy trial documents and lack of labeled data make trial similarity search difficult. We propose a zero-shot clinical trial retrieval method, Trial2Vec, which learns through self-supervision without annotating similar clinical trials. Specifically, the meta-structure of trial documents (e.g., title, eligibility criteria, target disease) along with clinical knowledge (e.g., UMLS knowledge base https://www.nlm.nih.gov/research/umls/index.html) are leveraged to automatically generate contrastive samples. Besides, Trial2Vec encodes trial documents considering meta-structure thus producing compact embeddings aggregating multi-aspect information from the whole document. We show that our method yields medically interpretable embeddings by visualization and it gets a 15% average improvement over the best baselines on precision/recall for trial retrieval, which is evaluated on our labeled 1600 trial pairs. In addition, we prove the pre-trained embeddings benefit the downstream trial outcome prediction task over 240k trials. Software ias available at https://github.com/RyanWangZf/Trial2Vec.

User Edit Pencil Streamline Icon: https://streamlinehq.com
Authors (2)
  1. Zifeng Wang (78 papers)
  2. Jimeng Sun (181 papers)
Citations (18)

Summary

Analysis of Trial2Vec: Zero-Shot Clinical Trial Document Similarity Search via Self-Supervision

The research presented in this paper introduces Trial2Vec, a novel method designed to enhance the retrieval of clinical trial documents by determining their similarity without reliance on labeled data. The method tackles a crucial challenge in clinical trial design: the need to reference and gather insights from related historical trials. Given the complexity and length of clinical trial documents, alongside the rarity of labeled data, traditional document retrieval systems often falter. Trial2Vec circumvents these issues through a self-supervised learning framework that exploits the inherent structure of clinical trial documents and leverages existing medical knowledge for improved retrieval efficacy.

Core Concepts and Methodology

Trial2Vec is a zero-shot retrieval method, meaning it does not necessitate labeled data to function effectively, differentiating it from other supervised document retrieval models. It relies on self-supervision facilitated by the meta-structure of clinical documents—such as titles, eligibility criteria, and target diseases—alongside the Unified Medical Language System (UMLS) knowledge base. This approach automatically generates contrastive samples that are essential for learning meaningful document embeddings.

The architecture of Trial2Vec is centered around several key components:

  • Hierarchical Encoding: Trial2Vec utilizes a hierarchical approach to process trial documents. It generates both local attribute embeddings and global document embeddings, enabling comprehensive incorporation of the trial’s structure.
  • Medical Knowledge Integration: The system leverages UMLS to refine the process of negative sampling within contrastive learning. This enhances the system's ability to create embeddings that are semantically rich and medically interpretable.
  • Contrastive Learning Techniques: The method uses innovative sampling strategies to create effective contrastive learning settings. By harnessing the meta-structure of trials, Trial2Vec constructs positive and negative sample pairs that improve its retrieval performance.

Empirical Evaluation and Results

Trial2Vec’s performance was evaluated on a clinical trial retrieval task comprising 1,600 manually labeled trial pairs and showcased a significant improvement over existing methods. The system achieved a 15% boost in average precision/recall compared to baseline models, which highlights its efficacy in filtering and ranking trials according to their relevance.

Moreover, Trial2Vec's pretrained embeddings were shown to benefit downstream tasks, such as predicting the outcomes of 240k trials. This suggests versatile applications beyond similarity retrieval, underscoring the potential of robust embedding methodologies to inform machine learning tasks in clinical research.

Implications and Future Directions

The implications of Trial2Vec's development are twofold. Practically, it provides a tool for more efficient clinical trial design by enabling researchers to access and utilize historical data more effectively, potentially saving time and resources in the drug development pipeline. Theoretically, it opens new avenues for research into zero-shot learning models for structured and unstructured document retrieval, particularly within specialized domains such as healthcare.

Future developments might include expanding Trial2Vec’s capabilities to embrace multilingual trial documents, enhancing the system's adaptability to diverse global data sources. Further refinement of its contrastive learning strategies and expansion of its knowledge base could also provide incremental performance improvements, tailoring the approach to the evolving complexities of clinical trial documentation.

Ultimately, while the methodology presented in this paper pushes the boundaries of zero-shot learning for document retrieval, ongoing research and iterative improvements will be crucial for maintaining the system's relevancy and applicability in real-world clinical settings.

Youtube Logo Streamline Icon: https://streamlinehq.com